CSL sinks to nine-year low on revenue warning, $5B write-down

CSL's stock has plummeted to its lowest level in nearly nine years following a revised revenue forecast that indicates a 4% decrease for the full year. The company also announced a significant $5 billion impairment charge, raising concerns among investors about its financial health and future performance.